Press Releases from DelveInsight Business Research (5349 total)
The PCSK9 Inhibitors Market to Increase Rapidly During the Forecast Period with …
"The increase in PCSK9 Inhibitors market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming…
Postmenopausal osteoporosis Pipeline Assessment - FDA, EMA, and PMDA Approvals, …
Postmenopausal osteoporosis pipeline constitutes 18+ key companies continuously working towards developing 18+ Postmenopausal osteoporosis treatment therapies, analyzes DelveInsight
Menopause can increase your risk of developing osteoporosis,…
Von Willebrand's Disease Pipeline Assessment - FDA, EMA, and PMDA Approvals, Eme …
Von Willebrand's Disease pipeline constitutes 4+ key companies continuously working towards developing 4+ Von Willebrand's Disease treatment therapies, analyzes DelveInsight
Most commonly inherited bleeding disorder, first…
Type 1 Diabetes Therapeutic Pipeline Analysis | Insights into the Latest FDA, EM …
As per DelveInsight's assessment, globally, around 80+ key pharma and biotech companies are working on 100+ pipeline drugs in the Type 1 Diabetes therapeutics landscape…
Acute Myeloid Leukemia Therapeutic Pipeline Analysis | Insights into the Latest …
As per DelveInsight's assessment, globally, nearly 260+ key pharma and biotech companies are working on 260+ pipeline drugs in the Acute Myeloid Leukemia therapeutics landscape…
Human Papillomavirus-positive Oropharyngeal Cancer Market to Witness Growth by 2 …
DelveInsight's "Human Papillomavirus-positive Oropharyngeal Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Human Papillomavirus-positive Oropharyngeal Cancer, historical and forecasted epidemiology…
Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breas …
DelveInsight's "Hormone Receptor (HR) Positive/ Human Epidermal Receptor 2 (HER2) Negative Breast Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of…
Myocardial Infarction Pipeline Assessment (2022): In-depth Analysis of Clinical …
Myocardial Infarction pipeline constitutes 50+ key companies continuously working towards developing 50+ Myocardial Infarction treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route…
Sickle Cell Disease Pipeline Assessment (2022): In-depth Analysis of Clinical Tr …
Sickle Cell Disease pipeline constitutes 40+ key companies continuously working towards developing 50+ Sickle Cell Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Nicotine Addiction Market to Register Impressive Growth During the Forecast Peri …
DelveInsight's "Nicotine Addiction Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as…
Diabetic Retinopathy Therapeutics Pipeline Analysis | Insights into the Clinical …
DelveInsight's latest report on "Diabetic Retinopathy Pipeline" depicts 60+ companies and 60+ pipeline drugs in the Diabetic Retinopathy Therapeutics landscape.
"Diabetic Retinopathy Pipeline Insight, 2022" report…
Fallopian tube cancer Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emergi …
Fallopian tube cancer pipeline constitutes 70+ key companies continuously working towards developing 70+ Fallopian tube cancer treatment therapies, analyzes DelveInsight
Fallopian tube cancer develops in the…
Oral Mucositis Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drug …
Oral mucositis pipeline constitutes 10+ key companies continuously working towards developing 10+ Oral mucositis treatment therapies, analyzes DelveInsight
Oral mucositis is a severely debilitating condition characterized…
Late-stage Chronic Kidney Disease (CKD) Market to Witness Growth by 2032, Estima …
DelveInsight's "Late-stage Chronic Kidney Disease (CKD) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Late-stage Chronic Kidney Disease (CKD), historical and…
HPV-induced Cutaneous Tumors Market to Witness Growth by 2032, Estimates DelveIn …
DelveInsight's "HPV-induced Cutaneous Tumors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of HPV-induced Cutaneous Tumors, historical and forecasted epidemiology as well…
HER2-Positive Early Breast Cancer Market to Witness Growth by 2032, Estimates De …
DelveInsight's "HER2-Positive Early Breast Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of HER2-Positive Early Breast Cancer, historical and forecasted epidemiology…
Hodgkin's Lymphoma Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hodgkin's lymphoma (HL) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hodgkin's lymphoma (HL), historical and forecasted epidemiology as well…
Inherited Retinal Disease Market to Witness Growth by 2032, Estimates DelveInsig …
DelveInsight's "Inherited Retinal Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Inherited Retinal Disease, historical and forecasted epidemiology as well…
Coronary Angioplasty with or without Stenting Market to Witness a Robust Growth …
DelveInsight's "Coronary Angioplasty with or without Stenting Market Insight & Forecast" report will offer an in-depth understanding of the Coronary Angioplasty with or without Stenting…
Dyskinesia Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, Lat …
DelveInsight's Dyskinesia Pipeline Insight 2022 report provides comprehensive insights about 40+ companies and 45+ pipeline drugs in the Dyskinesia pipeline landscape. It covers the pipeline…
Hemophilia B Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, L …
DelveInsight's Hemophilia B Pipeline Insight 2022 report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Hemophilia B pipeline landscape. It covers…
Sepsis Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, Latest …
Sepsis pipeline constitutes 40+ key companies continuously working towards developing 40+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration,…
Choroideremia Pipeline Assessment (2022): In-depth Analysis of Clinical Trials, …
Choroideremia pipeline constitutes 5+ key companies continuously working towards developing 5+ Choroideremia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration,…
Multiple sclerosis Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging …
Multiple sclerosis pipeline constitutes 100+ key companies continuously working towards developing 100+ Multiple sclerosis treatment therapies, analyzes DelveInsight
Multiple sclerosis (MS) is a chronic autoimmune disease…
Colorectal Cancer Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging D …
Colorectal Cancer pipeline constitutes 150+ key companies continuously working towards developing 150+ Colorectal Cancer treatment therapies, analyzes DelveInsight
Colorectal (bowel) cancer is one of the…
Brain Cancer Market is expected to increase at a CAGR of 1.11% in the 7MM for th …
DelveInsight's Brain Cancer Market Report proffers an all-encompassing view of the market trends, key pharmaceutical companies working in the Brain Cancer market, recent approvals, expected…
Acute Ischemic Stroke Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emergi …
Acute Ischemic Stroke pipeline constitutes 35+ key companies continuously working towards developing 35+ Acute Ischemic Stroke treatment therapies, analyzes DelveInsight
Acute strokes, also known as cerebrovascular…
Chronic Wounds Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drug …
Chronic Wounds pipeline constitutes 5+ key companies continuously working towards developing 5+ Chronic Wounds treatment therapies, analyzes DelveInsight
Wound healing is a complex, highly regulated process…
Common Warts Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drugs, …
Common Warts pipeline constitutes 5+ key companies continuously working towards developing 5+ Common Warts treatment therapies, analyzes DelveInsight
Warts are non-cancerous (benign) skin growths that develop…
Cryptococcal Meningitis Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emer …
Cryptococcal Meningitis pipeline constitutes 5+ key companies continuously working towards developing 5+ Cryptococcal Meningitis treatment therapies, analyzes DelveInsight
Cryptococcosis is an opportunistic infection that causes more…
Doose Syndrome Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emerging Drug …
Doose Syndrome pipeline constitutes 5+ key companies continuously working towards developing 5+ Doose Syndrome treatment therapies, analyzes DelveInsight
Doose syndrome, otherwise traditionally known as myoclonic-astatic epilepsy,…
Uterine Leiomyoma (Uterine Fibroids) Pipeline Assessment - FDA, EMA, and PMDA Ap …
Uterine Leiomyoma pipeline constitutes 10+ key companies continuously working towards developing 10+ Uterine Leiomyoma treatment therapies, analyzes DelveInsight
Uterine leiomyomata or fibroids are an extremely common…
According to DelveInsight, the Non Alcoholic Fatty Liver Disease Market in 7MM i …
DelveInsight's "Non Alcoholic Fatty Liver Disease Market" report provides a thorough comprehension of the Non Alcoholic Fatty Liver Disease, historical and forecasted epidemiology, and the…
According to DelveInsight, the Allergic Rhinitis market in 7MM is expected to wi …
DelveInsight's "Allergic Rhinitis Market" report provides a thorough comprehension of the Allergic Rhinitis, historical and forecasted epidemiology, and the Allergic Rhinitis market trends in the…
HER2-Positive Breast Cancer Clinical and Non-Clinical Studies, Key Companies, Th …
As per DelveInsight's assessment, globally, about 75+ companies are working on developing 75+ pipeline drugs in the HER2 Positive Breast Cancer pipeline landscape based on…
Dyskinesia Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessm …
As per DelveInsight's assessment, globally, around 50+ companies are developing 50+ therapies in the Dyskinesia pipeline landscape based on different routes of administration, Mechanism of…
Oncolytic virus cancer therapy Pipeline Assessment - FDA, EMA, and PMDA Approval …
Oncolytic virus cancer therapy pipeline constitutes 120+ key companies continuously working towards developing 125+ Oncolytic virus cancer treatment therapies, analyzes DelveInsight
The oncolytic viruses (OVs) are…
Hyperpigmentation Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hyperpigmentation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hyperpigmentation, historical and forecasted epidemiology as well as the Hyperpigmentation market…
Hypoventilation Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hypoventilation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hypoventilation, historical and forecasted epidemiology as well as the Hypoventilation market…
Food Allergy Market is Projected to Grow During the Forecast Period (2019-2032) …
As per DelveInsight, the Food Allergy Market is anticipated to grow in the coming years owing to the entry of novel desensitizing immunotherapies, backed by…
Biliary Atresia Market to Observe Stunning Growth by 2032, Evaluates DelveInsigh …
As per DelveInsight's assessment, the Biliary Atresia market is expected to grow in the coming years owing to the rise in the number of incident…
Acute Respiratory Distress Syndrome Pipeline Assessment - FDA, EMA, and PMDA App …
Acute Respiratory Distress Syndrome Pipeline constitute 32+ key companies continuously working toward developing Acute Respiratory Distress Syndrome treatment therapies, analyzes DelveInsight
The report comprises Acute…
Dry Age-related Macular Degeneration Pipeline Assessment - FDA, EMA, and PMDA Ap …
Dry Age-related Macular Degeneration pipeline constitute 36+ key companies continuously working toward developing Dry Age-related Macular Degeneration treatment therapies, analyzes DelveInsight
The report comprises Dry…
Severe Hypertriglyceridemia Pipeline Assessment - FDA, EMA, and PMDA Approvals, …
Severe Hypertriglyceridemia pipeline constitutes 10+ key companies continuously working towards developing 10+ Severe Hypertriglyceridemia treatment therapies, analyzes DelveInsight
Hypertriglyceridemia refers to a fasting plasma triglyceride measurement…
Severe Acne Vulgaris Pipeline Assessment - FDA, EMA, and PMDA Approvals, Emergin …
Severe Acne Vulgaris pipeline constitutes 10+ key companies continuously working towards developing 10+ Severe Acne Vulgaris treatment therapies, analyzes DelveInsight
Acne vulgaris is an inflammatory disorder…
Insights Into the Metastatic Pancreatic Cancer Therapeutic Pipeline, 2022 | Key …
Globally, around 25+ companies are working on developing 25+ pipeline drugs in the Metastatic Pancreatic Cancer pipeline landscape based on different routes of administration, molecule…
Osteoporosis Market Forecast, 2032 - Launch of the Emerging Therapies, Ongoing R …
As per DelveInsight, the Osteoporosis market size in the seven major markets was found to be $ 9,442.73 Million in 2017, which will increase by…
Hepatic Impairment Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Hepatic Impairment Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hepatic Impairment, historical and forecasted epidemiology as well as the…
Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2021 by D …
Global Vitreoretinal Surgery Devices Market was valued at USD 1.68 billion in 2021, growing at a CAGR of 7.69% during the forecast period from 2022…
Hemophilia A Market is expected to show positive growth, during the forecast per …
Hemophilia A Market Insights report from DelveInsight provides a thorough understanding of the Hemophilia A Market size by treatment, epidemiology, emerging therapies, market share of…
